Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05038345 · ClinicalTrials.gov registry record
Hirschsprung Disease Trends in the United States: Analysis of the National Inpatient Sample
A clinical trial, sponsored by University of New Mexico.
- Terminated
- Registry status
- 2,787
- Enrollment target
NCT05038345: Clinical Trial study, sponsored by University of New Mexico.
NCT05038345 is a clinical trial that was terminated before completion, run by University of New Mexico. The registered enrollment target is 2,787 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05038345 was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- 2,787 participants
- Enrollment target
Study Summary
Hirschsprung disease (HD) is associated with significant morbidities including long-term bowel dysfunction. The aim of this study was to update national and regional trends in the epidemiology and inpatient care utilization of HD in the United States between 2009 and 2014 using the National Inpatient Sample (NIS).
Interventions
- PROCEDURE Pull through surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,787 participants |
| Start Date | 2019-03-13 |
| Est. Completion | 2021-08-15 |
Why NCT05038345 stopped before completion
NCT05038345 is an observational study that tracks outcomes without assigning an intervention. Its 2,787 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Pull through surgery is the first listed.
NCT05038345 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05038345 about?
NCT05038345 is a clinical study titled "Hirschsprung Disease Trends in the United States: Analysis of the National Inpatient Sample". Hirschsprung disease (HD) is associated with significant morbidities including long-term bowel dysfunction. The aim of this study was to update national and regional trends in the epidemiology and inpatient care utilization of HD in the United States between 2009 and 2014 using the National Inpatien...
What is the current status of trial NCT05038345?
This trial is currently terminated. The enrollment target is 2,787 participants. The study started on 2019-03-13. Estimated completion is 2021-08-15.
What interventions are being tested in trial NCT05038345?
The interventions under investigation include: Pull through surgery (PROCEDURE).
Who is sponsoring clinical trial NCT05038345?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05443737 · 2,800 participants · Phase 3
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
- NCT05899439 · 2,800 participants
Immune Function and the Progression to T1D
- NCT06089109 · 2,800 participants · NA
Creating VIP Corps to Reduce Maternal Deaths
- NCT06345339 · 2,800 participants · Phase 2
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI